Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taxus Pharmaceuticals (Taxus İlaç) is a Turkish pharmaceutical company founded in 2011 and headquartered in Istanbul. The company focuses on the development, licensing, and commercialization of specialized medicinal products, with a strong emphasis on oncology, urology, and hematology. Taxus operates by providing high-quality branded generics and specialty drugs to the Turkish healthcare market, often collaborating with international partners for technology transfer and distribution. Their business model emphasizes improving patient access to critical therapies through a robust portfolio of injectable and oral formulations. The company maintains a strong presence in the hospital segment, particularly within the Turkish oncology network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taxus Pharmaceuticals.